CEP
SRDX

Chicago Equity Partners’s Surmodics SRDX Stock Holding History

Chicago Equity Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,185
Closed -$835K – 874
2018
Q3 		$835K Buy
11,185
+685
+7% +$47.2K 0.02% 564
2018
Q2 		$580K Hold
10,500
– – 0.02% 618
2018
Q1 		$400K Buy
+10,500
New +$325K 0.01% 646

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chicago Equity Partners's SRDX Position: Q4 2018 in Review

Chicago Equity Partners sold out of Surmodics (SRDX) in Q4 2018, closing a stake of 11,185 shares — an estimated $835K sold.

Chicago Equity Partners first reported a position in SRDX in Q1 2018 and held it in 3 quarters. The position peaked at $835K in Q3 2018. 161 funds tracked by Wall St. Rank hold SRDX as of Q4 2018.

  • Chicago Equity Partners reported no remaining Surmodics position as of Q4 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 11,185 Surmodics shares in Q4 2018, an estimated $835K.
  • Chicago Equity Partners first reported a position in Surmodics in Q1 2018 and held it in 3 quarters.
  • Chicago Equity Partners's Surmodics position peaked at $835K in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Surmodics as of Q4 2018.

Based on Chicago Equity Partners's 13F filing for Q4 2018, filed 5 Feb 2019.